Abstract
Progress in endoscopic equipment for laparoscopic surgery of uterine fibroids, in addition to unconditional number of advantag- es, is associated with the development of complications associated with the morcellation of myomatous nodes. Leaving of leio- myoma fragments contributes to parasitic nodes formation of various localization that requires additional surgery. We described a clinical case of removal of multiple parasitic myomatous nodes of iatrogenic nature. It was shown that laparoscopic surgery requires special attention not only to the operation technique, but also to postoperative management in order to prevent the development of adverse outcomes. One of the most important aspects of this preventive therapy is a thorough risk assessment and prevention of thrombotic complications. The use of Fluxum® may be an acceptable alternative to other low molecular weight heparins for prophylaxis of venous thromboembolic complications in high risk patients.
REFERENCES
1. Adamyan L.V., Andreeva E.N., Artymuk N.V. et al. Uterine my- oma: diagnosis, treatment and rehabilitation. Clinical recommen- dations (treatment protocol). [Mioma matki: diagnostika, lechenie i reabilitaciya. Klinicheskie rekomendacii (protokol lecheniya)]. Moskva, 2015. 100 s (in Russ.). Available at: http://docs.cntd.ru/ document/456019539.
2. Statistics Canada. Health indicators. Ottawa: Canadian Institute for Health Information, 2011. 145 s. Available at: https://secure. cihi.ca/free_products/health_indicators_2011_en.pdf.
3. Malinowski A., Makowska J., Antosiak B. Total laparoscopic hys- terectomy — indications and complications of 158 patients. Ginekol Pol. 2013;84(4):252–7.
4. Erian J., Hassan M., Hill N. Electromechanical morcellation in laparoscopic subtotal hysterectomy. Int J Gynaecol Obstet. 2007;99(1):67–8. DOI: 10.1016/j.ijgo.2007.04.014.
5. Darii N., Anton E., Doroftei B. et al. Iatrogenic parasitic my- oma and iatrogenic adenomyoma after laparoscopic morcel- lation: A mini-review. J Adv Res. 2019;20:1–8. DOI: 10.1016/j. jare.2019.04.004.
6. Cucinella G., Granese R., Calagna G. et al. Parasitic myomas af- ter laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril. 2011;96(2): e90–6. DOI: 10.1016/j.fertnstert.2011.05.095.
7. Raine-Bennett T., Tucker L.Y., Zaritsky E. et al. Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associ- ated with morcellation. Obstet Gynecol. 2016;127(1):29–39. DOI: 10.1097/AOG.0000000000001187.
8. Reich H., DeCaprio J., McGlynn F. Laparoscopic hysterectomy. J Gynecol Surg. 1989;5(2):213–6. DOI: 10.1089/gyn.1989.5.213.
9. Steiner R.A., Wight E., Tadir Y., Haller U. Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity. Ob- stet Gynecol. 1993;81(3):471–4.
10. Glaser L.M., Friedman J., Tsai S. et al. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines. Best Pract Res Clin Obstet Gynaecol. 2018;46:99–112. DOI: 10.1016/j.bpobgyn.2017.09.012.
11. Van der Meulen J.F., Pijnenborg J.M., Boomsma C.M. et al. Par- asitic myoma after laparoscopic morcellation: a systematic re- view of the literature. BJOG. 2016;123:69–75. DOI: 10.1111/1471– 0528.13541.
12. Morozov K.M., Kolbin A.S., Galankin T.L. Network meta-anal- ysis for parnaparin effectiveness in venous thromboembolism prevention in surgery. [Cetevoj meta-analiz effektivnosti prim- eneniya parnaparina dlya profilaktiki venoznyh tromboemboli- cheskih oslozhnenij pri hirurgicheskih vmeshatel’stvah]. Tromboz, gemostaz i reologiya. 2018;(1): 31–39 (in Russ.). DOI: 10.25555/ THR .2018.1.0821.
13. Satti M.A., Paredes Saenz C., Raju R. et al. Should prophylac- tic anticoagulation be considered with large uterine leiomyoma? A case series and literature review. Case Rep Obstet Gynecol. 2016;2016:9803250. DOI: 10.1155/2016/9803250.
14. Grishin I.I. Uterine artery embolization. New technologies in op- erative gynecology and obstetrics. [Embolizaciya matochnyh ar- terij. Novye tekhnologii v operativnoj ginekologii i akusherstve]. Avtoref. dis. dokt. med. nauk. Moskva, 2014. 44 s (in Russ.).
15. Camporese G., Bernardi E., Noventa F. Update on the clinical use of the low-molecular-weight heparin, parnaparin. Vasc Health Risk Manag. 2009;5:819–31. DOI: 10.2147/vhrm.s3430.
16. Elbiss H.M., Abu-Zidan F.M. Bowel injury following gynecolog- ical laparoscopic surgery. Afr Health Sci. 2017;17(4):1237–45. DOI:10.4314/ahs.v17i4.35.
